Never Bet Against Occam: Mast Cell Activation Syndrome and the Modern Epidemics of Chronic Illness and Medical Complexity
Dr. Afrin earned a B.S. in computer science at Clemson University in 1984 and then an M.D. at the Medical University of South Carolina (MUSC) in 1988, where he also pursued internal medicine residency and hematology/oncology clinical and research fellowships. While on faculty at MUSC from 1995-2014, he was active in undergraduate and graduate medical education, educational and information technology administration, and practice and research in hematology/oncology and medical informatics. Since the mid-’00s, his clinical work has increasingly focused in hematology, especially mast cell disease. In 2008 Dr. Afrin started coming to understand that a newly recognized type of mast cell disease, now called mast cell activation syndrome (MCAS), was the underlying diagnosis in many patients he was seeing who were each suffering large assortments — quite different from one patient to the next — of chronic multisystem inflammatory illnesses of unclear cause. Dr. Afrin soon gained experience that MCAS is far more prevalent than the only mast cell disease previously known to medicine (the rare disease of mastocytosis) and that most MCAS patients, once accurately diagnosed, can eventually find significantly helpful medications targeted at the disease. The frequency and magnitude of the improvements Dr. Afrin has seen — even the relief that comes from finally having a unifying diagnosis other than “psychosomatism” — have spurred him to focus in this area, not only tending to the needs of his patients but also pursuing research to advance our understanding of the disease and helping to educate other professionals who in turn can help even more of the many people who have long been suffering not only the symptoms of the disease but also the natural concern of not understanding why one would be so “unlucky” to have acquired so many medical problems. As it turns out, such patients are not so unlucky and truly have just one root issue (and a very common one at that) which has the biological capability to develop, directly or indirectly, into most or all their previously diagnosed problems. There is a great deal yet to learn about this, but even with just the present very limited understanding, the opportunity to diagnose and help patients with MCAS seems to be enormous and Dr. Afrin felt a description of the disease, written for the general public, might help lead some MCAS patients on a journey to diagnosis and improvement sooner rather than later. He joined the University of Minnesota in 2014 to further his interests in this area. He has an extensive record of peer-reviewed publications and has spoken widely in his areas of interest.”
Dr. Afrin hopes this book will help people who might have, or do have, MCAS. A portion of the proceeds of purchases of this book will go to support research and education in this area.
Never Bet Against Occam: Mast Cell Activation Disease and The Modern Epidemics of Chronic Illness and Medical Complexity is available in both paperback and hardcover print, and digital/eBook via Amazon.com, Barnes and Nobel.com, and other online retailers.
Additional ways to connect:
– Mast Cell Research’s Facebook Page: https://www.facebook.com/mastcellresearch/
– The Never Bet Against Occam book fan page – https://www.facebook.com/Never-Bet-Against-Occam-Mast-Cell-Activation-Disease-976505815732570/
– Join the Never Bet Against Occam/Mast Cell Research book club – https://www.facebook.com/Never-Bet-Against-Occam-Mast-Cell-Activation-Disease-976505815732570/
– Follow @MastCellHelp for the last information on Dr. Afrin’s widely popular book, and links to additional publications on mast cell research and Mast Cell Activation Disorders.
Published by Sisters Media, LLC – March 15, 2016. Copyright & trademark protected.
Sisters Media, LLC is a media company focused on the publishing of digital and print materials in the fields of health, medical and wellness, including non-fiction books and anthologies, as well as on photography and design projects.